Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
07:08 PM, 23rd Dec 2024
Audio Recording of Analysts/Investors Call pertaining to the acquisition of international rights for the active ingredients Iprovalicarb and Triadimenol by the Company from Bayer AG Germany.